NCT02969174Approved For Marketing不适用
Clinical Professor of Shanghai Tongji Hospital
Shanghai Tongji Hospital, Tongji University School of Medicine0 个研究点开始时间: 2016年11月21日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- Approved For Marketing
- 发起方
研究概览
简要总结
To establish a genotyping and extraction technology of non invasive prenatal diagnosis for fetal blood group genotype from cell-free fetal DNA in peripheral blood of pregnant women.
To achieve prenatal accurate identification of fetal blood group genotypes，and provide credible theoretical evidence for the prenatal diagnosis and treatment of hemolytic disease of newborn (HDN).
详细描述
Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.
研究设计
- 研究类型
- Expanded Access
入排标准
- 年龄范围
- 12 Weeks 至 38 Weeks（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •blood samples of pregnant couples,gender/nation/region is unlimited.
排除标准
- •adipose or hemolytic samples,overdue samples,unidentified samples
研究者
Liming Cheng
The President of Shanghai Tongji Hospital
Shanghai Tongji Hospital, Tongji University School of Medicine
相似试验
Unknown
不适用
Noninvasive Prenatal Diagnosis: Using Fetal Cells From Maternal BloodChromosome DisordersNCT00064597Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3,500
已完成
不适用
High Risk Multiple Gestation StudyTrisomy 18Trisomy 21Sex Chromosome AbnormalitiesTrisomy 13NCT02278874Natera, Inc.99
Unknown
不适用
Non Invasive Prenatal Testing (NIPT) of Single-gene DisordersHereditary DiseaseNCT02339402Maastricht University Medical Center160
已完成
不适用
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal BloodTrisomy 21Trisomy 18Sex Chromosome AbnormalitiesMicrodeletion SyndromesTrisomy 13NCT01852708Natera, Inc.1,059
已完成
不适用
Multiple Gestation StudyTrisomy 18Trisomy 21Sex Chromosome AbnormalitiesTrisomy 13NCT02278536Natera, Inc.354